Miyuki Miki

714 total citations
20 papers, 363 citations indexed

About

Miyuki Miki is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Miyuki Miki has authored 20 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in Miyuki Miki's work include Multiple Myeloma Research and Treatments (4 papers), IgG4-Related and Inflammatory Diseases (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Miyuki Miki is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), IgG4-Related and Inflammatory Diseases (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Miyuki Miki collaborates with scholars based in Japan and China. Miyuki Miki's co-authors include Tomoyuki Sakai, Masao Tanaka, Yasufumi Masaki, Toshihiro Fukushima, Akio Nakajima, Yoshimasa Fujita, Hisanori Umehara, Haruka Iwao, Toshioki Sawaki and Takafumi Kawanami and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cellular Immunology.

In The Last Decade

Miyuki Miki

20 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyuki Miki Japan 11 123 108 96 73 72 20 363
Haruka Iwao Japan 12 139 1.1× 149 1.4× 99 1.0× 113 1.5× 107 1.5× 22 472
Masahiro Yokosawa Japan 13 64 0.5× 186 1.7× 95 1.0× 68 0.9× 67 0.9× 38 443
Rebecca Hasseli Germany 10 67 0.5× 136 1.3× 58 0.6× 23 0.3× 35 0.5× 26 341
Toshio Kakihara Japan 12 110 0.9× 39 0.4× 60 0.6× 89 1.2× 19 0.3× 47 410
Paola Cagnati Italy 10 94 0.8× 93 0.9× 25 0.3× 76 1.0× 51 0.7× 11 436
Carol R. Drucker United States 9 251 2.0× 84 0.8× 18 0.2× 27 0.4× 60 0.8× 13 477
Shunli Tang China 11 38 0.3× 98 0.9× 90 0.9× 47 0.6× 87 1.2× 24 496
Rayford R. June United States 10 69 0.6× 105 1.0× 40 0.4× 23 0.3× 36 0.5× 12 415
Dennis Niebel Germany 14 121 1.0× 97 0.9× 49 0.5× 43 0.6× 60 0.8× 51 542
Lindsay B. Kelmenson United States 7 42 0.3× 388 3.6× 75 0.8× 22 0.3× 56 0.8× 8 578

Countries citing papers authored by Miyuki Miki

Since Specialization
Citations

This map shows the geographic impact of Miyuki Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Miki more than expected).

Fields of papers citing papers by Miyuki Miki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Miki. The network helps show where Miyuki Miki may publish in the future.

Co-authorship network of co-authors of Miyuki Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Miki. A scholar is included among the top collaborators of Miyuki Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Miki. Miyuki Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujita, Yoshimasa, Takao Fujii, Tomomi Sato, et al.. (2016). Isolation of vascular smooth muscle antigen-reactive CD4+αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas mice. Cellular Immunology. 303. 50–54. 1 indexed citations
2.
Kurose, Nozomu, Takafumi Kawanami, Takuji Nakamura, et al.. (2015). <b>CD14</b><sup><b>+</b></sup><b> follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related </b><b>disease </b>. Biomedical Research. 36(2). 143–153. 11 indexed citations
3.
Masaki, Yasufumi, Tomomi Nakamura, Takuji Nakamura, et al.. (2014). IgG4-Related Disease: Diagnostic Methods and Therapeutic Strategies in Japan. Journal of Clinical and Experimental Hematopathology. 54(2). 95–101. 33 indexed citations
4.
Fujita, Yoshimasa, Takao Fujii, Tsuneyo Mimori, et al.. (2014). Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice. The Journal of Immunology. 192(3). 979–984. 43 indexed citations
5.
Masaki, Yasufumi, Akio Nakajima, Haruka Iwao, et al.. (2013). Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity?. Journal of Clinical and Experimental Hematopathology. 53(1). 79–85. 72 indexed citations
6.
Fukushima, Toshihiro, Tomomi Sato, Takuji Nakamura, et al.. (2012). Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.. PubMed. 32(12). 5437–40. 11 indexed citations
7.
Kawanami, Takafumi, Toshioki Sawaki, Tomoyuki Sakai, et al.. (2012). Skewed Production of IL-6 and TGFβ by Cultured Salivary Gland Epithelial Cells from Patients with Sjögren's Syndrome. PLoS ONE. 7(10). e45689–e45689. 23 indexed citations
8.
Fukushima, Toshihiro, Haruka Iwao, Tomoyuki Sakai, et al.. (2012). [Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report].. PubMed. 39(5). 805–7. 2 indexed citations
9.
Fukushima, Toshihiro, Hiroshi Kawabata, Toshioki Sawaki, et al.. (2012). Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.. PubMed. 32(4). 1347–53. 9 indexed citations
10.
Masaki, Yasufumi, Haruka Iwao, Akio Nakajima, et al.. (2011). IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems. Current Immunology Reviews. 7(2). 172–177. 4 indexed citations
11.
Masaki, Yasufumi, Miyuki Miki, Takuji Nakamura, et al.. (2011). High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma. International Journal of Hematology. 93(6). 720–726. 13 indexed citations
12.
Masaki, Yasufumi, Miyuki Miki, Tomoyuki Sakai, et al.. (2011). [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].. PubMed. 63(5). 435–41. 3 indexed citations
13.
Fukushima, Toshihiro, Hiroshi Kawabata, Takuji Nakamura, et al.. (2011). Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.. PubMed. 31(5). 1741–4. 54 indexed citations
14.
Fukushima, Toshihiro, Takuji Nakamura, Haruka Iwao, et al.. (2011). Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events.. PubMed. 31(6). 2297–302. 19 indexed citations
15.
Miki, Miyuki, Yasufumi Masaki, Takuji Nakamura, et al.. (2010). [Primary neurolymphomatosis of the cervical nerve root].. PubMed. 51(7). 564–7. 2 indexed citations
16.
Fukushima, Toshihiro, Takuji Nakamura, Miyuki Miki, et al.. (2010). Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas.. PubMed. 30(9). 3791–4. 5 indexed citations
17.
Cao, Yan, Zhe-Xiong Jin, Xiaopeng Tong, et al.. (2010). Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.. PubMed. 30(10). 3911–7. 8 indexed citations
18.
Jin, Zhe-Xiong, Lingli Dong, Xiaopeng Tong, et al.. (2010). Cisplatin augments FAS-mediated apoptosis through lipid rafts.. PubMed. 30(6). 2065–71. 23 indexed citations
19.
Fukushima, Toshihiro, Haruka Iwao, Miyuki Miki, et al.. (2009). MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.. PubMed. 29(8). 3361–4. 7 indexed citations
20.
Fukushima, Toshihiro, Lei Dong, Tomoyuki Sakai, et al.. (2008). Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus. Lupus. 17(3). 210–214. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruka Iwao Breakdown of academic impact, for papers by Masahiro Yokosawa Breakdown of academic impact, for papers by Rebecca Hasseli Breakdown of academic impact, for papers by Toshio Kakihara Breakdown of academic impact, for papers by Paola Cagnati Breakdown of academic impact, for papers by Carol R. Drucker Breakdown of academic impact, for papers by Shunli Tang Breakdown of academic impact, for papers by Rayford R. June Breakdown of academic impact, for papers by Dennis Niebel Breakdown of academic impact, for papers by Lindsay B. Kelmenson
Rankless by CCL
2026